Home › NDC Lookup › Ingredients › Simethicone › 70677-1077-01
Foster and Thrive Extra Strength Gas Relief Cherry Simethicone 125 mg Tablet, Chewable — NDC 70677-1077-01 package photo

Foster and Thrive Extra Strength Gas Relief Cherry Simethicone 125 mg Tablet, Chewable

by Strategic Sourcing Services LLC · 2 BLISTER PACK in 1 CARTON (70677-1077-1) / 9 TABLET, CHEWABLE in 1 BLISTER PACK
NDC 70677-1077-01
🏷️ FDA NDC (as labeled) 70677-1077-1 billing pads the package segment with a zero
OTC On market Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

🆔 Identity & classification

FDA NDC (as labeled) 70677-1077-1
Product NDC 70677-1077
11-digit billing NDC 70677107701
NCPDP billing unit EA — each (per item)
RxCUI 314221
UNII 92RU3N3Y1O
Application # M002
SPL Set ID e47374c8-05c1-4874-871b-e83d9b305bd3
Physiologic effect Skin Barrier Activity
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2023-05-25
Route ORAL
Dosage form TABLET, CHEWABLE
Substance DIMETHICONE
GPI-14 52200020000530
GCN Seq No 002819
GCN 08282
HICL code 001224
Ingredient (HICL) Simethicone
HIC1 code D
Therapeutic class — broad (HIC1) Biliary System/Gastro-Intestinal System
HIC2 code D4
Therapeutic class — intermediate (HIC2) Drugs Acting Principally On The Alimentary Tract
HIC3 code D4N
Therapeutic class — specific (HIC3) Antiflatulents
AHFS code 56:10.00.00
AHFS class Antiflatulents
FDB label name FT GAS RELIEF 125 MG CHEW TAB
FDB brand name Gas Relief
Legend status O — Over-the-counter (OTC) drug or device
Why two NDCs? The FDA registers this code as 70677-1077-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 70677-1077-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏭 Manufacturer & labeler

LabelerStrategic Sourcing Services LLC
FDA applicationM002 (OTC MONOGRAPH DRUG)
Labeler code70677
First marketedMay 2023
Product typeHuman Otc Drug
Portfolio316 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

Label name FT GAS RELIEF 125 MG CHEW TAB Ingredient Simethicone
📖 What it is MedlinePlus · NLM

Simethicone is used to treat the symptoms of gas such as uncomfortable or painful pressure, fullness, and bloating. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • Simethicone works to relieve the uncomfortable pressure, bloating, and full or stuffed feeling that comes from trapped gas in your stomach or intestines. It's used when gas builds...
  • What exactly does simethicone do for gas?
  • Yes — there are infant-specific simethicone products, like Mylicon Infants Gas Relief and similar infant drops, designed just for babies. They're used to relieve gas discomfort tha...
  • Can I give simethicone drops to my baby?
📖 Read our full Simethicone guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

💊 What it looks like

Color Pink
ShapeRound
ImprintG134
Size14 mm
ScoringNot scored
FlavorCherry
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
  • UNII 2S42T2808B
    A synthetic red dye used as a colorant to give the medicine its red color. It helps make pills or liquids visually distinct and easier to identify.
  • UNII IY9XDZ35W2
    Dextrose is a simple sugar derived from corn or other sources. It serves as a filler and sweetener in medicines to add bulk, improve taste, and help stabilize the medication's form.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII 7CVR7L4A2D
    A starch-derived carbohydrate produced by breaking down corn, potato, or tapioca starch. It functions as a filler and binder to give the medicine bulk and texture, and sometimes as a mild sweetener or texture enhancer in powders and tablets.
  • UNII 506T60A25R
    Sorbitol is a natural sugar alcohol derived from glucose. It serves as a sweetener, humectant, and bulking agent in medications to improve taste and help maintain moisture in the product.
  • UNII C151H8M554
    A natural sugar derived from sugar cane or sugar beets. It's used as a sweetener, filler, and binder to improve taste, add bulk, and help hold tablet or capsule ingredients together.

7 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesD&C red # 30 aluminum lake, dextrose, flavor, magnesium stearate, maltodextrin, microcrystalline cellulose, sorbitol, sucrose.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.104 $1.87 / 18 tablets
Medicaid paysCMS SDUD · 12 mo $0.1709 $3.08 / 18 tablets
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Dec 2023 Dec 2025 Apr 2026 Aug 2026 $0.108 $0.096
▲ Up 8% over the last 12 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
gas relief 125 mg 62011-0189-01 Strategic 9 tablets $0.097 — FDA listed save 7%
Rugby Gas relief 125 mg 00536-1223-08 Rugby 60 tablets $0.104 — Availability likely —
extra strength Gas Relief cherry creme 125 mg 46122-0811-08 Amerisource 9 tablets $0.104 — Availability likely —
Foster and Thrive Extra Strength Gas Relief Cherry 125 mgthis 70677-1077-01 Strategic 9 tablets $0.104 — Availability likely —
Gas-X Extra Strength 125 mg 00067-0117-01 Haleon 12 tablets — — FDA listed —
Gas-X Extra Strength 125 mg 00067-0129-18 Haleon 9 tablets — — FDA listed —
Walgreens Extra Strength 125 mg 00363-0118-18 WALGREENS 9 tablets — — FDA listed —
Extra Strength Gas Relief 125 mg 00363-0119-18 WALGREENS 9 tablets — — FDA listed —
Gas Relief - Cherry Flavor 125 mg 11673-0066-48 TARGET 12 tablets — — FDA listed —
up and up extra strength gas relief chewables Extra Strength 125 mg 11673-0610-48 Target 12 tablets — — FDA listed —
Gas Relief 125 mg 11822-6080-02 Rite 12 tablets — — FDA listed —
Simethicone 125 mg 17714-0040-60 Advance 60 tablets — — FDA listed —
Simethicone 125 mg 17856-0137-01 ATLANTIC 1 tablet — — FDA listed —
Extra Strength Gas Relief 125 mg 21130-0110-18 SAFEWAY 6 tablets — — FDA listed —
Gas Relief 125 mg 21130-0135-73 Safeway 9 tablets — — FDA listed —
Extra Strength Gas Relief 125 mg 21130-0441-18 SAFEWAY 9 tablets — — FDA listed —
Kroger Extra Strength Gas Relief 125 mg 30142-0481-48 KROGER 4 tablets — — FDA listed —
Gas Relief 125 mg 36800-0122-73 Topco 6 tablets — — FDA listed —
TopCare Extra Strength Gas Relief Cherry Creme 125 mg 36800-0488-48 TOPCO 48 tablets — — FDA listed —
HEB Gas Relief Extra Strength Peppermint 125 mg 37808-0155-73 H 9 tablets — — FDA listed —
Extra Strength Gas Relief Cherry 125 mg 37808-0692-13 H 12 tablets — — FDA listed —
Extra Strength Simethicone 125 mg 37835-0233-18 Bi-Mart 9 tablets — — FDA listed —
gas relief 125 mg 41163-0408-44 United 9 tablets — — FDA listed —
Extra Strength gas relief 125 mg 41415-0110-18 PUBLIX 6 tablets — — FDA listed —
Extra Strength Gas Relief 125 mg 42507-0701-34 Hyvee 9 tablets — — FDA listed —
Extra Strength Gas Relief 125 mg 49035-0910-48 Wal-Mart 48 tablets — — FDA listed —
Extra Strength Gas Relief Cherry 125 mg 50804-0134-73 Good 9 tablets — — FDA listed —
CVS PHARMACY Extra Strength Gas Relief 125 mg 51316-0011-18 CVS 9 tablets — — FDA listed —
CVS PHARMACY Extra Strength 125 mg 51316-0110-18 CVS 9 tablets — — FDA listed —
Extra Strength Gas Relief Cherry Creme 125 mg 51316-0134-13 CVS 9 tablets — — FDA listed —
Extra Strength Gas Relief Cherry Flavor 125 mg 53943-0134-39 Discount 9 tablets — — FDA listed —
Gas Relief Extra Strength 125 mg 55301-0680-44 ARMY 9 tablets — — FDA listed —
Family Wellness Extra Strength Gas Relief Cherry 125 mg 55319-0134-34 Family 12 tablets — — FDA listed —
Extra Strength Gas Relief 125 mg 57896-0694-03 Geri-Care 30 tablets — — FDA listed —
Mylanta Gas Minis Mint Flavor 125 mg 62372-0800-50 Infirst 50 tablets — — FDA listed —
Mylanta Gas Minis Assorted Fruit Flavor 125 mg 62372-0801-03 Infirst 3 tablets — — Discontinued —
Best Choice Extra Strength 125 mg 63941-0110-18 BEST 9 tablets — — FDA listed —
WinCo FOODS Extra Strength Gas Relief 125 mg 67091-0361-18 WINCO 6 tablets — — FDA listed —
Premier Value Extra Strength 125 mg 68016-0811-18 PHARMACY 9 tablets — — FDA listed —
Extra Strength Gas Relief Cherry 125 mg 69256-0134-73 Harris 9 tablets — — FDA listed —
Extra Strength Gas Relief 125 mg 69256-0135-73 Harris 9 tablets — — FDA listed —
Simethicone 125 mg 69618-0032-06 Reliable 60 tablets — — FDA listed —
Gas-Aid 125 mg 69626-7197-03 Leosons 9 tablets — — FDA listed —
Firstcare Gas Relief Simethicone 125 mg Anti-gas 71594-0709-10 USpharma 100 tablets — — FDA listed —
Extra Strength Gas Relief Cherry 125 mg 72476-0134-73 Retail 9 tablets — — FDA listed —
Gas Relief 125 mg 79481-0608-04 Meijer 9 tablets — — FDA listed —
Gas Relief 125 mg 80136-0859-68 Heartland 100 tablets — — FDA listed —
Wonderbelly Extra Strength Anti-Gas 125 mg 82431-0201-02 Ginger 2 tablets — — Discontinued —
Wonderbelly Extra Strength Anti-Gas 125 mg 82431-0202-02 Ginger 2 tablets — — Discontinued —
Wonderbelly Extra Strength Anti-Gas 125 mg 82431-0203-02 Ginger 2 tablets — — Discontinued —
Wonderbelly Extra Strength Anti-Gas 82431-0291-10 Ginger 10 tablets — — Discontinued —
Simethicone 125 mg 82804-0152-09 Proficient 9 tablets — — FDA listed —
QCH Extra Strength Gas Relief Cherry Flavor 134CHR 125 mg 83324-0132-18 Chain 9 tablets — — FDA listed —
Gas Relief 125 mg 83324-0325-18 Chain 9 tablets — — FDA listed —
Pepto Gas plus Bloating 125 mg 84126-0378-16 The 16 tablets — — FDA listed —
Maximum Strength Antacid Mint 125 mg 53041-0100-23 Guardian 60 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2023
On the market since
May 2023
📍
2026
Currently FDA-listed
3 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🗺️ Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for 70677-1077-01, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q4 2025 · 4 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
801
Units reimbursed last 4 qtrs
46.5K
Gross reimbursed last 4 qtrs
$7.9K
Avg / prescription
$9.92
Avg / unit
$0.1709
Latest quarter Q4 2025
130Rx
Medicaid pays / ea
$0.1709
gross reimbursed
vs
NADAC / ea
$0.1041
acquisition cost
=
Spread
+$0.0668
+64% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
54% FFS 46% MCO
Fee-for-service · 433 Rx Managed care · 368 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 16,262 units · 283 per 100k residents MN Wisconsin: no data reported WI Michigan: 2,394 units · 23.9 per 100k residents MI New York: 17,969 units · 91.8 per 100k residents NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: no data reported OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: no data reported IN Ohio: 2,702 units · 22.9 per 100k residents OH Pennsylvania: 1,640 units · 12.7 per 100k residents PA New Jersey: 999 units · 10.8 per 100k residents NJ Massachusetts: no data reported MA California: 1,844 units · 4.7 per 100k residents CA Utah: no data reported UT Colorado: no data reported CO Nebraska: 1,963 units · 99.2 per 100k residents NE Missouri: no data reported MO Kentucky: 720 units · 15.9 per 100k residents KY West Virginia: no data reported WV Virginia: no data reported VA Maryland: no data reported MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: no data reported AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: no data reported HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
4.7283
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Minnesota 283 /100k
2 Nebraska 99.2 /100k
3 New York 91.8 /100k
4 Michigan 23.9 /100k
5 Ohio 22.9 /100k
6 Kentucky 15.9 /100k
7 Pennsylvania 12.7 /100k
8 New Jersey 10.8 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Foster and Thrive Extra Strength Gas Relief Cherry (this brand).

Top reported reactions

Nausea106
Fatigue83
Diarrhoea79
Vomiting70
Abdominal Pain67
Dyspnoea66
Pain58

Age at onset

Neonate2
Infant1
Child9
Adolescent6
Adult27
Elderly11

Reporter sex

1,061 reports

Serious outcomes

Hospitalization565
Death150
Life-threatening68
Disabling29
Reports over time (by year) — tap or hover for the count & year
2022 2023 2024 2026 9 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
70677-1077-01 You're viewing this 2 BLISTER PACK in 1 CARTON (70677-1077-1) / 9 TABLET, CHEWABLE in 1 BLISTER PACK 2023-05-25 Active

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose
🎯 Indications and Usage 9 words ▾

USE(S) relieves: pressure bloating symptoms referred to as gas

⏱️ Dosage and Administration 33 words ▾

DIRECTIONS chew 1 to 2 tablets thoroughly as needed after meals and at bedtime do not exceed 4 tablets in a 24 hour period except under the advice and supervision of a physician.

⚠️ Warnings 2 words ▾

WARNINGS .

📦 Storage and Handling 27 words ▾

OTHER INFORMATION do not use if any individual blister unit is broken or open store at room temperature avoid high humidity and excessive heat, above 40ºC (104ºF)

🧪 Active Ingredient 7 words ▾

ACTIVE INGREDIENT(in each tablet) Simethicone 125 mg

🧪 Inactive Ingredients 17 words ▾

INACTIVE INGREDIENTS D&C red # 30 aluminum lake, dextrose, flavor, magnesium stearate, maltodextrin, microcrystalline cellulose, sorbitol, sucrose.

🎯 Purpose 2 words ▾

PURPOSE Anti-gas

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 70677-1076-01 · Strategic 70677-1078-01 · Strategic →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.